ProSci has developed SARS-CoV-2 variant-specific reagents by focusing on unique point mutations in the spike protein.
SARS-CoV-2 Recombinant Virus Lineages
The Role of Monoclonal Antibodies & Biosimilars in Life Science Research
mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.
Monoclonal Antibody Drugs for Cancer
Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.
StemBioSys CELLvo™ Human Atrial iPS-Cardiomyocytes
CELLvo™ Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes cultured on CELLvo™ Matrix Plus. Achieve maturation in 7 days.
Correlation Between HLA Typing and Immune Monitoring in Human Disease
The human leukocyte antigen system, aka human major histocompatibility complex, was named after its discovery with alloantibodies against leukocytes.
Quantitatively Detect Residual Protease in Samples
LeadGene ELISA kits to quantitatively detect residual protease in samples.
Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
Insights into the Molecular Mechanisms Regulating Necroptosis
This white paper details findings in molecular mechanisms that govern necroptosis related to RIPK & details #2283 use to analyse expression of RIPK3.
Exploring the Roles of RIPKs in Immune Responses, Inflammation, and Cell Death: Recent Findings
ProSci has 25+ years expertise in developing antibodies. This white paper details use of RIPK antibodies & findings on RIPKs in signalling pathways.
A Deep Dive into the Hidden Power of Programmed Cell Death: Unlocking Therapeutic Potential with Antibodies
ProSci has 25+ years of expertise in developing antibodies. This white paper details use of ProSci antibodies in the study of programmed cell death.